Zacks Investment Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Sell |
512,301
-6,540
| -1% | -$7.39K | 0.01% | 458 |
|
|
2025
Q1 | $758K | Buy |
518,841
+37,967
| +8% | +$55.4K | 0.01% | 430 |
|
|
2024
Q4 | $1.02M | Sell |
480,874
-35,727
| -7% | -$76.1K | 0.01% | 417 |
|
|
2024
Q3 | $1.45M | Buy |
+516,601
| New | +$1.45M | 0.01% | 376 |
|
|
2024
Q2 | – | Sell |
-459,800
| Closed | -$2.06M | – | 622 |
|
|
2024
Q1 | $2.06M | Buy |
459,800
+67,357
| +17% | +$301K | 0.02% | 307 |
|
|
2023
Q4 | $1.26M | Buy |
+392,443
| New | +$1.26M | 0.02% | 353 |
|